ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $120,487,697.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$185.24

▲ +3.07 (1.69%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/17/2024	Richard A. Gonzalez	Chairman	Sell	282,845	$175.00	$49,497,875.00	513,099
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00
11/2/2021	Roxanne S. Austin	Director	Sell	51,844	$116.38	$6,033,604.72
8/23/2021	Carrie C. Strom	SVP	Sell	5,057	$120.00	$606,840.00	11,595

J.P. Morgan’s DIRE Warning

From Behind the Markets | Ad

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Financial Connections Group Inc.	1,200	$0.21M	0.1%	+9.7%	0.000%
7/26/2024	MWA Asset Management	16,534	$2.84M	2.0%	+1.6%	0.001%
7/26/2024	Worth Financial Advisory Group LLC	3,127	$0.54M	0.4%	-6.5%	0.000%
7/26/2024	Hall Capital Management Co. Inc.	17,580	$3.02M	1.4%	-1.2%	0.001%
7/26/2024	Harbour Investments Inc.	23,121	$3.97M	0.1%	+3.6%	0.001%
7/26/2024	LS Investment Advisors LLC	12,274	$2.11M	0.3%	+1.8%	0.001%
7/26/2024	Park Edge Advisors LLC	3,921	$0.67M	0.2%	-6.0%	0.000%
7/26/2024	Eagle Bay Advisors LLC	9,714	$1.67M	1.0%	+4.0%	0.001%
7/26/2024	Patriot Financial Group Insurance Agency LLC	4,001	$0.69M	0.1%	+1.5%	0.000%
7/26/2024	AustralianSuper Pty Ltd	9,078	$1.56M	0.0%	+8.4%	0.001%
7/26/2024	Atomi Financial Group Inc.	11,857	$2.03M	0.2%	-9.1%	0.001%
7/26/2024	Cambridge Investment Research Advisors Inc.	477,267	$81.86M	0.3%	-0.4%	0.027%
7/26/2024	Groesbeck Investment Management Corp NJ	7,279	$1.25M	1.7%	-67.5%	0.000%
7/26/2024	Legato Capital Management LLC	14,390	$2.47M	0.3%	+21.1%	0.001%
7/26/2024	Summit Securities Group LLC	800	$0.14M	0.0%	-98.0%	0.000%
7/26/2024	Dearborn Partners LLC	219,817	$37.70M	1.6%	-0.9%	0.012%
7/26/2024	AlphaStar Capital Management LLC	27,577	$4.73M	0.4%	+4.7%	0.002%
7/26/2024	Railway Pension Investments Ltd	649,968	$111.48M	1.3%	-27.9%	0.037%
7/26/2024	Latitude Advisors LLC	2,632	$0.45M	0.3%	+2.7%	0.000%
7/26/2024	Gold Investment Management Ltd.	11,062	$1.90M	0.8%	-9.1%	0.001%
7/26/2024	Signature Estate & Investment Advisors LLC	6,018	$1.03M	0.0%	+246.1%	0.000%
7/26/2024	Allspring Global Investments Holdings LLC	519,544	$89.11M	0.1%	+1.7%	0.029%
7/26/2024	State of Michigan Retirement System	483,608	$82.95M	0.4%	-3.3%	0.027%
7/26/2024	First Command Advisory Services Inc.	5,707	$0.98M	0.0%	N/A	0.000%
7/26/2024	Callan Family Office LLC	3,113	$0.53M	0.1%	+30.6%	0.000%
7/26/2024	Hyman Charles D	29,433	$5.05M	0.3%	-0.5%	0.002%
7/26/2024	Alpha Omega Wealth Management LLC	56,520	$9.69M	1.9%	-2.3%	0.003%
7/26/2024	SlateStone Wealth LLC	42,611	$7.31M	0.8%	-8.3%	0.002%
7/26/2024	Rational Advisors LLC	1,473	$0.25M	0.0%	N/A	0.000%
7/26/2024	Bailard Inc.	17,488	$3M	0.1%	-15.8%	0.001%
7/26/2024	Verdence Capital Advisors LLC	21,162	$3.63M	0.3%	+3.5%	0.001%
7/26/2024	Paulson Wealth Management Inc.	7,094	$1.22M	0.4%	-3.2%	0.000%
7/26/2024	Bank of New York Mellon Corp	17,528,854	$3.01B	0.6%	-11.6%	0.993%
7/26/2024	Catalyst Financial Partners LLC	12,296	$2.11M	0.5%	+9.6%	0.001%
7/26/2024	Bristlecone Advisors LLC	1,801	$0.31M	0.0%	-6.2%	0.000%
7/26/2024	Salomon & Ludwin LLC	4,882	$0.84M	0.1%	-34.3%	0.000%
7/26/2024	TFG Advisers LLC	20,926	$3.59M	1.4%	+0.4%	0.001%
7/26/2024	Alta Capital Management LLC	3,235	$0.56M	0.0%	-3.7%	0.000%
7/26/2024	IMA Advisory Services Inc.	10,513	$1.80M	0.4%	-2.4%	0.001%
7/26/2024	Van Strum & Towne Inc.	31,631	$5.43M	2.0%	-0.4%	0.002%
7/25/2024	New Millennium Group LLC	319	$55K	0.0%	N/A	0.000%
7/25/2024	Addison Capital Co	8,242	$1.41M	0.6%	-1.0%	0.000%
7/25/2024	apricus wealth LLC	19,165	$3.29M	2.3%	-0.7%	0.001%
7/25/2024	Easterly Investment Partners LLC	6,172	$1.06M	0.1%	-38.5%	0.000%
7/25/2024	Cypress Capital Group	113,931	$19.54M	2.3%	-0.8%	0.006%
7/25/2024	Raymond James Trust N.A.	168,193	$28.85M	0.7%	+3.9%	0.010%
7/25/2024	Wedgewood Investors Inc. PA	2,232	$0.38M	0.5%	N/A	0.000%
7/25/2024	Highland Capital Management LLC	23,168	$3.97M	0.2%	-12.4%	0.001%
7/25/2024	Capital Advisors Ltd. LLC	4,453	$0.76M	0.1%	+1.3%	0.000%
7/25/2024	Calamos Advisors LLC	449,504	$77.10M	0.3%	-2.4%	0.025%
7/25/2024	Northcape Wealth Management LLC	11,782	$2.02M	0.7%	+11.9%	0.001%
7/25/2024	AMG National Trust Bank	27,191	$4.66M	0.1%	+26.4%	0.002%
7/25/2024	Sigma Investment Counselors Inc.	39,617	$6.80M	0.4%	+1.2%	0.002%
7/25/2024	Tempus Wealth Planning LLC	2,867	$0.49M	0.2%	+11.6%	0.000%
7/25/2024	Calamos Wealth Management LLC	8,159	$1.40M	0.1%	-6.5%	0.000%
7/25/2024	Access Financial Services Inc.	8,823	$1.51M	0.7%	-0.9%	0.000%
7/25/2024	Independence Bank of Kentucky	16,521	$2.83M	0.8%	+5.7%	0.001%
7/25/2024	Optas LLC	3,905	$0.67M	0.2%	+9.0%	0.000%
7/25/2024	Clear Creek Financial Management LLC	3,340	$0.57M	0.1%	+7.1%	0.000%
7/25/2024	Pinnacle Wealth Management Advisory Group LLC	11,127	$1.91M	0.2%	-1.1%	0.001%
7/25/2024	Destiny Wealth Partners LLC	4,881	$0.84M	0.2%	-2.7%	0.000%
7/25/2024	Harbor Advisory Corp MA	23,895	$4.10M	1.4%	-6.3%	0.001%
7/25/2024	Moody Lynn & Lieberson LLC	155,315	$26.64M	1.7%	-10.3%	0.009%
7/25/2024	Waypoint Capital Advisors LLC	4,257	$0.73M	0.2%	+3.8%	0.000%
7/25/2024	Shelter Ins Retirement Plan	57,585	$9.88M	2.6%	N/A	0.003%
7/25/2024	Sterling Investment Counsel LLC	7,235	$1.24M	0.5%	+6.5%	0.000%
7/25/2024	Institute for Wealth Management LLC.	20,252	$3.47M	0.5%	+0.5%	0.001%
7/25/2024	RPS Advisory Solutions LLC	3,361	$0.58M	0.5%	N/A	0.000%
7/25/2024	Fullcircle Wealth LLC	6,394	$1.13M	0.5%	N/A	0.000%
7/25/2024	Washburn Capital Management Inc.	5,232	$0.90M	0.6%	-2.8%	0.000%
7/25/2024	Cape ANN Savings Bank	4,013	$0.69M	0.4%	-53.9%	0.000%
7/25/2024	Kanawha Capital Management LLC	148,846	$25.53M	2.0%	+4.7%	0.008%
7/25/2024	Etesian Wealth Advisors Inc.	10,127	$1.74M	1.0%	+0.7%	0.001%
7/25/2024	Destination Wealth Management	2,004	$0.34M	0.0%	+26.4%	0.000%
7/25/2024	Mn Services Vermogensbeheer B.V.	697,804	$119.69M	0.9%	-2.5%	0.040%
7/25/2024	Bank Pictet & Cie Europe AG	196,581	$33.72M	0.8%	+5.6%	0.011%
7/25/2024	Banque Pictet & Cie SA	99,634	$17.09M	0.2%	+15.4%	0.006%
7/25/2024	First Merchants Corp	29,171	$5M	0.2%	-0.8%	0.002%
7/25/2024	Nichols & Pratt Advisers LLP MA	27,235	$4.67M	0.3%	-2.5%	0.002%
7/25/2024	Bank of Stockton	6,610	$1.13M	0.4%	-20.9%	0.000%
7/25/2024	Beacon Capital Management LLC	1,689	$0.29M	0.1%	+5.1%	0.000%
7/25/2024	Monarch Capital Management Inc.	52,778	$9.05M	2.7%	-1.0%	0.003%
7/25/2024	Atlantic Union Bankshares Corp	95,298	$16.35M	1.0%	+191.2%	0.005%
7/24/2024	McAdam LLC	17,221	$2.95M	0.2%	+0.8%	0.001%
7/24/2024	Argent Capital Management LLC	104,764	$17.97M	0.5%	-78.0%	0.006%
7/24/2024	LRI Investments LLC	9,252	$1.59M	0.2%	+77.6%	0.001%
7/24/2024	EdgeRock Capital LLC	1,716	$0.29M	0.2%	+21.5%	0.000%
7/24/2024	EWA LLC	1,631	$0.28M	0.1%	+6.2%	0.000%
7/24/2024	Advisory Resource Group	1,887	$0.32M	0.1%	-4.5%	0.000%
7/24/2024	White Pine Investment CO	1,522	$0.26M	0.1%	-8.3%	0.000%
7/24/2024	Keynote Financial Services LLC	41,046	$7.04M	5.8%	+0.6%	0.002%
7/24/2024	Grove Bank & Trust	12,710	$2.18M	0.3%	-1.2%	0.001%
7/24/2024	Retirement Systems of Alabama	955,408	$163.87M	0.6%	-3.4%	0.054%
7/24/2024	West Oak Capital LLC	9,083	$1.56M	0.6%	-4.9%	0.001%
7/24/2024	Horizon Bancorp Inc. IN	2,050	$0.35M	0.2%	-29.6%	0.000%
7/24/2024	Quotient Wealth Partners LLC	6,733	$1.16M	0.0%	+11.5%	0.000%
7/24/2024	Herold Advisors Inc.	39,149	$6.72M	1.6%	+2.1%	0.002%
7/24/2024	Van Lanschot Kempen Investment Management N.V.	37,574	$6.45M	0.1%	+15.6%	0.002%
7/24/2024	Avitas Wealth Management LLC	24,356	$4.18M	0.6%	-1.0%	0.001%
7/24/2024	Everhart Financial Group Inc.	11,686	$2M	0.5%	+9.3%	0.001%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $185.24

$182.17

$186.85

50 Day Range

MA: $167.68

$154.86

$185.24

52 Week Range

Now: $185.24

$135.85

$186.85

Volume

6,948,346 shs

Average Volume

5,572,868 shs

Market Capitalization

$327.11 billion

P/E Ratio

54.97

Dividend Yield

3.52%

Beta

0.64

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
Bank of New York Mellon Corp — 0.99%
Raymond James & Associates — 0.26%
Sumitomo Mitsui Trust Holdings Inc. — 0.23%
Swedbank AB — 0.12%
New York State Teachers Retirement System — 0.10%
Fifth Third Bancorp — 0.09%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Bank of New York Mellon Corp
Argent Capital Management LLC
Sumitomo Mitsui Trust Holdings Inc.
Railway Pension Investments Ltd
Guinness Asset Management LTD
Artemis Investment Management LLP
Portman Square Capital LLP
New York State Teachers Retirement System
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
Assenagon Asset Management S.A.
Raymond James & Associates
M&G Plc
Swedbank AB
DNB Asset Management AS
TCW Group Inc.
Atlantic Union Bankshares Corp
Dupont Capital Management Corp